Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neuro-Oncology"
DOI: 10.1007/s11060-022-03989-7
Abstract: Programmable ventriculoperitoneal shunts (pVP shunts) are increasingly utilized for intraventricular chemotherapy, radioimmunotherapy, and/or cellular therapy. Shunt adjustments allow optimization of drug concentrations in the thecal space with minimization in the peritoneum. This report assesses the… read more here.
Keywords: drug; programmable ventriculoperitoneal; drug delivery; access device ... See more keywords
Effect of exposure from iPhone 12 on programmable ventriculoperitoneal shunts
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Neurosurgery"
DOI: 10.1080/02688697.2022.2028724
Abstract: Abstract The latest iPhone 12 model has elicited concerns over its interaction with medical devices such as pacemakers due to its integrated MagSafe technology. Historically, programmable ventriculoperitoneal (VP) shunts have been demonstrated to readjust when… read more here.
Keywords: ventriculoperitoneal shunts; effect exposure; programmable ventriculoperitoneal; iphone ... See more keywords